EA200900985A1 - Способ получения оптически чистого омепразола - Google Patents
Способ получения оптически чистого омепразолаInfo
- Publication number
- EA200900985A1 EA200900985A1 EA200900985A EA200900985A EA200900985A1 EA 200900985 A1 EA200900985 A1 EA 200900985A1 EA 200900985 A EA200900985 A EA 200900985A EA 200900985 A EA200900985 A EA 200900985A EA 200900985 A1 EA200900985 A1 EA 200900985A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- omeprazol
- obtaining optical
- optical pure
- optically pure
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
Abstract
Настоящее изобретение относится к способу получения, по существу, оптически чистого омепразола или его фармацевтически приемлемой соли или сольвата. Изобретение также относится к способу получения фармацевтической композиции, содержащей, по существу, оптически чистый омепразол или его фармацевтически приемлемую соль или сольват, и к полупродуктам, полезным для получения оптически чистого омепразола.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200700024A SI22447A (sl) | 2007-01-31 | 2007-01-31 | Nov postopek za pripravo enantiomerno obogatenega omeprazola |
SI200700078A SI22490A (sl) | 2007-03-28 | 2007-03-28 | Nov postopek za pripravo enantiomerno obogatenegaomeprazola |
EP07019823A EP2048144A1 (en) | 2007-10-10 | 2007-10-10 | Process for the preparation of optically pure omeprazole via salt formation with a chiral amine |
PCT/EP2008/051230 WO2008092939A2 (en) | 2007-01-31 | 2008-01-31 | Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200900985A1 true EA200900985A1 (ru) | 2009-12-30 |
Family
ID=39638287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200900985A EA200900985A1 (ru) | 2007-01-31 | 2008-01-31 | Способ получения оптически чистого омепразола |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2114919A2 (ru) |
EA (1) | EA200900985A1 (ru) |
WO (1) | WO2008092939A2 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2346854A4 (en) * | 2008-11-18 | 2012-10-17 | Hetero Research Foundation | OPTICAL PURIFICATION OF ESOMEPRAZOLE |
WO2011042910A2 (en) * | 2009-10-09 | 2011-04-14 | Hetero Research Foundation | Optical resolution of substituted 2-(2- pyridinylmethylsulphinyl)-1h-benzimidazoles |
US8748619B2 (en) | 2009-11-12 | 2014-06-10 | Hetero Research Foundation | Process for the resolution of omeprazole |
WO2013088272A1 (en) * | 2011-12-14 | 2013-06-20 | Wockhardt Limited | Pharmaceutical composition comprising esomeprazole magnesium dihydrate |
CN102775418B (zh) * | 2012-06-11 | 2014-12-24 | 中国人民解放军第四军医大学 | 新型手性季铵盐相转移催化剂的合成及应用 |
CN106632248A (zh) * | 2016-09-30 | 2017-05-10 | 青岛云天生物技术有限公司 | 一种左旋泮托拉唑钠的制备工艺 |
CN112666304B (zh) * | 2019-10-15 | 2022-12-09 | 扬子江药业集团有限公司 | 一种艾司奥美拉唑钠药物中对映异构体的检测方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8204879D0 (sv) | 1982-08-26 | 1982-08-26 | Haessle Ab | Novel chemical intermediates |
DK171989B1 (da) | 1987-08-04 | 1997-09-08 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler |
AT391693B (de) | 1988-11-15 | 1990-11-12 | Cl Pharma | Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer |
SE9002043D0 (sv) | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
ES2026761A6 (es) | 1990-10-31 | 1992-05-01 | Genesis Para La Investigacion | Procedimiento de obtencion del omeprazol. |
WO1993006097A1 (en) | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
ATE259807T1 (de) * | 1996-06-05 | 2004-03-15 | Lindner Wolfgang Prof Dr | Auf cinchonan basierte chirale selektoren zur trennung von stereoisomeren |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
UA72748C2 (en) | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
DE69911159T2 (de) * | 1999-01-06 | 2004-06-24 | Técnimede-Sociedade Técnico-Medicinal, S.A. | Cyclodextrin Einschlusskomplexe mit Aminosäuresalzen von Benzimidazolderivaten, deren Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen |
SI20875A (sl) | 2001-04-25 | 2002-10-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristalna oblika omeprazola |
SE0104295D0 (sv) | 2001-12-18 | 2001-12-18 | Astrazeneca Ab | New process |
WO2003074514A1 (en) | 2002-03-05 | 2003-09-12 | Astrazeneca Ab | Alkylammonium salts of omeprazole and esomeprazole |
BR0315574A (pt) | 2002-10-22 | 2005-09-20 | Ranbaxy Lab Ltd | Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação |
WO2004099182A1 (en) * | 2003-05-05 | 2004-11-18 | Ranbaxy Laboratories Limited | Zinc salt of (s)-omeprazole |
EP1633736A1 (en) | 2003-05-05 | 2006-03-15 | Ranbaxy Laboratories Limited | Barium salt of benzimidazole derivative |
SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts I |
EP1726305A1 (de) | 2005-05-25 | 2006-11-29 | Ratiopharm GmbH | Zinksalz des Omeprazols und dessen Enantiomere |
ES2281292B1 (es) * | 2006-03-08 | 2008-06-16 | Quimica Sintetica S.A. | Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden. |
-
2008
- 2008-01-31 EA EA200900985A patent/EA200900985A1/ru unknown
- 2008-01-31 EP EP08708540A patent/EP2114919A2/en not_active Withdrawn
- 2008-01-31 WO PCT/EP2008/051230 patent/WO2008092939A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2114919A2 (en) | 2009-11-11 |
WO2008092939A2 (en) | 2008-08-07 |
WO2008092939A3 (en) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118721T1 (el) | Παραγωγα 2,3 διϋδρο-1η-ινδεν-1-υλ-2,7-διαζασπειρο[3.6]εννεανιου και η χρηση αυτων ως ανταγωνιστες ή αντιστροφοι αγωνιστες του υποδοχεα γκρελινης | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
EA200900985A1 (ru) | Способ получения оптически чистого омепразола | |
EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
DK1928503T3 (da) | Fremgangsmåde til fremstilling af oprensede lægemiddelkonjugater | |
WO2008008539A3 (en) | Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
WO2006072393A3 (de) | Sulfonylpyrrolidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
DK2019683T4 (da) | Indgivelse af vækstfaktorer til behandling af CNS-lidelser | |
ES2338590T3 (es) | Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos. | |
EA200870262A1 (ru) | Способ получения оптических активных хиральных аминов | |
EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
NO20090175L (no) | Stabile laquinimod sammensetninger | |
MX2012003539A (es) | Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac). | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
EA201100358A1 (ru) | Дабигатран для чрескожной хирургической катетеризации сердца | |
CL2007003158A1 (es) | Procedimiento de preparacion de compuestos derivados de quinazolina o sus sales farmaceuticamente aceptables; compuestos intermediarios; procedimiento de preparacion. | |
EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
DE602005007765D1 (de) | Neue indol- oder benzimidazol-derivate | |
EA201000039A1 (ru) | Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль |